In silico screening with benzofurane- and benzopyrane-type MDR-modulators
- 31 March 2003
- journal article
- Published by Elsevier BV in Il Farmaco
- Vol. 58 (3), 185-191
- https://doi.org/10.1016/s0014-827x(03)00021-1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The medicinal chemistry of multidrug resistance (MDR) reversing drugsIl Farmaco, 2002
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- A Method for the Synthesis of 2,3-Disubstituted 2,3-DihydrobenzofuransMonatshefte für Chemie / Chemical Monthly, 2000
- BBB transport and P-glycoprotein functionality using MDR1A (-/-) and wild-type mice. Total brain versus microdialysis concentration profiles of rhodamine-123.Pharmaceutical Research, 1998
- Quantitative Structure-Activity Relationship of Multidrug Resistance Reversal AgentsMolecular Pharmacology, 1997
- Structure−Activity Relationship Studies on Benzofuran Analogs of Propafenone-Type Modulators of Tumor Cell Multidrug ResistanceJournal of Medicinal Chemistry, 1996
- Clinical trials of agents that reverse multidrug resistance. A literature reviewCancer, 1993
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells.Proceedings of the National Academy of Sciences of the United States of America, 1988
- Synthèse et activité anti-allergique de quelques alcools benzopyroniques et apparentésEuropean Journal of Medicinal Chemistry, 1988